Link	ID	doc_name	has_clinical	Year	acute/sustained	sample group size	outcome count	disease	outcome direction	gnotobiotic	animal strain	animal sex	animal age value (days)	animal age description	animal weight value (g)	animal weight description	species	mechanism_of_action	disease model	intervention delivery	success measure	tested dose dependently	prophylactic / therapeutic	ribotype	c diff strain	c diff dose value	c diff dose units	c diff dose vegetative/spores	c diff dose description	daily dosage	total dosage	dosage value	dosage units	dosage times per day	dosage duration	dosage description	intervention	comparator	accute efficacy	sustained efficacy	comment	Done?	matched	result
https://pubmed.ncbi.nlm.nih.gov/77366	77366	77366.txt	TRUE	1978	acute	4	4	C. difficile	positive	n/a	goldensyrian	n/a	42	1-2 months		N/A	hamster		challenge	clindamycin+challenge	deathfromenterocolitis	f	p		na	13	cfu		13								negativecontrol	Negative Control	inferior	NA	pretreatment with vancomycin, 3mg/ml in water for 1 week until 2-3 days before expt, more data with different strains	Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/77366	77366	77366.txt	TRUE	1978	acute	4	0	C. difficile	positive	n/a	goldensyrian	n/a	42	1-2 months		N/A	hamster		challenge	clindamycin+challenge	deathfromenterocolitis	f	p		na	13	cfu		13	3		3	mg/ml		7		vancomycin	Negative Control	inferior	NA	pretreatment with vancomycin, 3mg/ml in water for 1 week until 2-3 days before expt, more data with different strains	Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/26917573	26917573	26917573.txt	TRUE	2016	acute	13	6	Clostridium difficile infection	positive	n/a	c57bl/6	m	504	18 months		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5								oldcontrol	vancomycin 50 mg/kg	superior	NA		Y	TRUE	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/26917573	26917573	26917573.txt	TRUE	2016	acute	8	8	Clostridium difficile infection	positive	n/a	c57bl/6	m	504	18 months		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	250	50	mg/kg	qd	5		vancomycin	old control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	26917573	26917573.txt	TRUE	2016	sustained	8	2	Clostridium difficile infection	positive	n/a	c57bl/6	m	504	18 months		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	250	50	mg/kg	qd	5		vancomycin	old control	superior	NA		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/26917573	26917573	26917573.txt	TRUE	2016	acute	13	7	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	2 months		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5								youngcontrol	vancomycin 50 mg/kg	superior	NA		Y	TRUE	0.5384615384615384
https://pubmed.ncbi.nlm.nih.gov/26917573	26917573	26917573.txt	TRUE	2016	acute	8	8	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	2 months		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	250	50	mg/kg	qd	5		vancomycin	young control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	26917573	26917573.txt	TRUE	2016	sustained	8	8	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	2 months		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	250	50	mg/kg	qd	5		vancomycin	young control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/33305657	33305657	33305657.txt	TRUE	2020	acute	12	12	Clostridioides difficile	positive	n/a	c57bl/6	n/a	84	2-4 months		N/A	mouse		neomycin+metronidazole+vancomycin+clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	1000		spores	1000	1000	1000	10^3	spores	qd	1		ntcd-035	Negative Control	superior	NA	made up numbers, proportions are correct	Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/33305657	33305657	33305657.txt	TRUE	2020	acute	12	4	Clostridioides difficile	positive	n/a	c57bl/6	n/a	84	2-4 months		N/A	mouse		neomycin+metronidazole+vancomycin+clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	1000		spores	1000								negativecontrol	NTCD-035	superior	NA	made up numbers, proportions are correct	Y	TRUE	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	4	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	0.3	1.5	0.3	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.4
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	3	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	0.3	1.5	0.3	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	10	50	10	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	100	500	100	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	12.5	62.5	12.5	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	12.5	62.5	12.5	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	25	125	25	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	25	125	25	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	3	15	3	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	3	15	3	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	20	20	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	30	150	30	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	30	150	30	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	300	1500	300	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	300	1500	300	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	50	250	50	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	20	20	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	50	250	50	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	30	2	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5								control	Negative Control	superior	superior		Y	TRUE	0.06666666666666667
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	2	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	0.3	1.5	0.3	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	0	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	0.3	1.5	0.3	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	4	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	10	50	10	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.4
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	8	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	100	500	100	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	4	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	12.5	62.5	12.5	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.4
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	3	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	12.5	62.5	12.5	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	6	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	25	125	25	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	4	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	25	125	25	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	0.4
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	2	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	3	15	3	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	6	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	3	15	3	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	20	10	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	30	150	30	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	8	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	30	150	30	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	6	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	300	1500	300	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	8	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	300	1500	300	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	10	4	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	50	250	50	mg/kg	qd	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.4
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	20	20	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	50	250	50	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	30	2	C. difficile disease	positive	n/a	goldensyrian	m	58	45-70 days	111	98-124g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5								control	Negative Control	superior	superior		Y	TRUE	0.06666666666666667
https://pubmed.ncbi.nlm.nih.gov/23689716	23689716	23689716.txt	TRUE	2013	acute	8	2	C. difficile disease	positive	axenic	n/a	n/a	5	5 days		N/A	pig		challenge		cumulativemortality	t	t	27	uk6	1000000		spores	10^6								control	vancomycin	inferior	NA		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/23689716	23689716	23689716.txt	TRUE	2013	acute	9	8	C. difficile disease	positive	axenic	n/a	n/a	5	5 days		N/A	pig		challenge		cumulativemortality	t	t	27	uk6	1000000		spores	10^6	200	1400	100	mg/kg	bid	7		mbx-500	vancomycin	inferior	NA		Y	TRUE	0.8888888888888888
https://pubmed.ncbi.nlm.nih.gov/23689716	23689716	23689716.txt	TRUE	2013	acute	4	3	C. difficile disease	positive	axenic	n/a	n/a	5	5 days		N/A	pig		challenge		cumulativemortality	t	t	27	uk6	1000000		spores	10^6	400	2800	200	mg/kg	bid	7		mbx-500	vancomycin	inferior	NA		Y	TRUE	0.75
https://pubmed.ncbi.nlm.nih.gov/23689716	23689716	23689716.txt	TRUE	2013	acute	6	6	C. difficile disease	positive	axenic	n/a	n/a	5	5 days		N/A	pig		challenge		cumulativemortality	t	t	27	uk6	1000000		spores	10^6	800	5600	400	mg/kg	bid	7		mbx-500	Negative Control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23689716	23689716	23689716.txt	TRUE	2013	acute	4	4	C. difficile disease	positive	axenic	n/a	n/a	5	5 days		N/A	pig		challenge		cumulativemortality	t	t	27	uk6	1000000		spores	10^6	40	280	20	mg/kg	bid	7		vancomycin	Negative Control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	acute	10	0	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	0.04	0.2	0.04	mg/kg	qd	5		fidaxomicin	1 mg/kg vancomycin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	acute	10	0	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	0.04	0.2	0.04	mg/kg	qd	5		vancomycin	1 mg/kg fidaxomicin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	acute	10	3	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	0.2	1	0.2	mg/kg	qd	5		fidaxomicin	1 mg/kg vancomycin	equivalent	equivalent		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	acute	10	0	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	0.2	1	0.2	mg/kg	qd	5		vancomycin	1 mg/kg fidaxomicin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	acute	10	10	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	1	5	1	mg/kg	qd	5		fidaxomicin	1 mg/kg vancomycin	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	acute	10	5	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	1	5	1	mg/kg	qd	5		vancomycin	1 mg/kg fidaxomicin	equivalent	equivalent		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	acute	10	10	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	5	25	5	mg/kg	qd	5		fidaxomicin	1 mg/kg vancomycin	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	acute	10	10	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	5	25	5	mg/kg	qd	5		vancomycin	1 mg/kg fidaxomicin	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	acute	10	0	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6								vehiclecontrol	1 mg/kg fidaxomicin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	sustained	10	0	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	0.04	0.2	0.04	mg/kg	qd	5		fidaxomicin	1 mg/kg vancomycin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	sustained	10	0	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	0.04	0.2	0.04	mg/kg	qd	5		vancomycin	1 mg/kg fidaxomicin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	sustained	10	0	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	0.2	1	0.2	mg/kg	qd	5		fidaxomicin	1 mg/kg vancomycin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	sustained	10	0	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	0.2	1	0.2	mg/kg	qd	5		vancomycin	1 mg/kg fidaxomicin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	sustained	10	3	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	1	5	1	mg/kg	qd	5		fidaxomicin	1 mg/kg vancomycin	equivalent	equivalent		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	sustained	10	5	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	1	5	1	mg/kg	qd	5		vancomycin	1 mg/kg fidaxomicin	equivalent	equivalent		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	sustained	10	9	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	5	25	5	mg/kg	qd	5		fidaxomicin	1 mg/kg vancomycin	equivalent	equivalent		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	sustained	10	9	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6	5	25	5	mg/kg	qd	5		vancomycin	1 mg/kg fidaxomicin	equivalent	equivalent		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	33495229	33495229.txt	TRUE	2021	sustained	10	0	Clostridioides difficile	positive	spf	goldensyrian	m	39	5-6 weeks		N/A	hamster		challenge+clindamycin	challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		10^6								vehiclecontrol	1 mg/kg fidaxomicin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25824219	25824219	25824219.txt	TRUE	2015	acute	10	9	"Clostridium difficile 
 
 infection"	positive	spf	c57bl/6	m	39	5-6 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4	50	250	50	mg/kg	qd	5		vancomycin	untreated control	superior	superior		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/25824219	25824219	25824219.txt	TRUE	2015	acute	10	2	"Clostridium difficile 
 
 infection"	positive	spf	c57bl/6	m	39	5-6 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4								untreatedcontrol	vancomycin	inferior	inferior		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/25824219	25824219	25824219.txt	TRUE	2015	sustained	10	3	"Clostridium difficile 
 
 infection"	positive	spf	c57bl/6	m	39	5-6 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4	50	250	50	mg/kg	qd	5		vancomycin	untreated control	superior	superior		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/25824219	25824219	25824219.txt	TRUE	2015	sustained	10	2	"Clostridium difficile 
 
 infection"	positive	spf	c57bl/6	m	39	5-6 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4								untreatedcontrol	vancomycin	inferior	inferior		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/26461425	26461425	26461425.txt	TRUE	2015	acute	10	8	Clostridium difficile	positive	n/a	c57bl/6	f	39	5-6 weeks		N/A	mouse		ampicillin,kanamycin,gentamycin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	p	27	uk6	10000000		spores	10^7	2000000	4000000	10^6	vegetativecells	bid	2		clostridiumdifficilecd37	control	inferior	inferior		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/26461425	26461425	26461425.txt	TRUE	2015	acute	10	2	Clostridium difficile	positive	n/a	c57bl/6	f	39	5-6 weeks		N/A	mouse		ampicillin,kanamycin,gentamycin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	p	27	uk6	10000000		spores	10^7								control	Clostridium difficile CD37	inferior	inferior		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/23324518	23324518	23324518.txt	TRUE	2013	acute	11	8	C. difficile disease	positive	n/a	goldensyrian	m	54	54 days	93	82-103g	hamster	antibody	clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	3.4x10^6	100	500	50	mg/kg	bid	5		mdx	Negative Control	superior	superior		Y	TRUE	0.7272727272727273
https://pubmed.ncbi.nlm.nih.gov/23324518	23324518	23324518.txt	TRUE	2013	acute	11	11	C. difficile disease	positive	n/a	goldensyrian	m	54	54 days	93	82-103g	hamster	antibody	clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	3.4x10^6	100	500	50	mg/kg	bid	5		ucb	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23324518	23324518	23324518.txt	TRUE	2013	acute	11	8	C. difficile disease	positive	n/a	goldensyrian	m	54	54 days	93	82-103g	hamster	antibody	clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	3.4x10^6	10	50	5	mg/kg	bid	5		mdx	UCB	inferior	inferior		Y	TRUE	0.7272727272727273
https://pubmed.ncbi.nlm.nih.gov/23324518	23324518	23324518.txt	TRUE	2013	acute	11	11	C. difficile disease	positive	n/a	goldensyrian	m	54	54 days	93	82-103g	hamster	antibody	clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	3.4x10^6	10	50	5	mg/kg	bid	5		ucb	MDX 	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23324518	23324518	23324518.txt	TRUE	2013	acute	5	5	C. difficile disease	positive	n/a	goldensyrian	m	54	54 days	93	82-103g	hamster	antibody	clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	3.4x10^6	10	50	5	mg/kg	bid	5		vancomycin	Negative Control	superior	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23324518	23324518	23324518.txt	TRUE	2013	sustained	11	2	C. difficile disease	positive	n/a	goldensyrian	m	54	54 days	93	82-103g	hamster	antibody	clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	3.4x10^6	100	500	50	mg/kg	bid	5		mdx	Negative Control	superior	superior		Y	TRUE	0.18181818181818182
https://pubmed.ncbi.nlm.nih.gov/23324518	23324518	23324518.txt	TRUE	2013	sustained	11	8	C. difficile disease	positive	n/a	goldensyrian	m	54	54 days	93	82-103g	hamster	antibody	clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	3.4x10^6	100	500	50	mg/kg	bid	5		ucb	Negative Control	superior	superior		Y	TRUE	0.7272727272727273
https://pubmed.ncbi.nlm.nih.gov/23324518	23324518	23324518.txt	TRUE	2013	sustained	11	1	C. difficile disease	positive	n/a	goldensyrian	m	54	54 days	93	82-103g	hamster	antibody	clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	3.4x10^6	10	50	5	mg/kg	bid	5		mdx	UCB	inferior	inferior		Y	TRUE	0.09090909090909091
https://pubmed.ncbi.nlm.nih.gov/23324518	23324518	23324518.txt	TRUE	2013	sustained	11	0	C. difficile disease	positive	n/a	goldensyrian	m	54	54 days	93	82-103g	hamster	antibody	clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	3.4x10^6	10	50	5	mg/kg	bid	5		ucb	MDX 	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/23324518	23324518	23324518.txt	TRUE	2013	sustained	5	0	C. difficile disease	positive	n/a	goldensyrian	m	54	54 days	93	82-103g	hamster	antibody	clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	3.4x10^6	10	50	5	mg/kg	bid	5		vancomycin	Negative Control	superior	inferior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/29483125	29483125	29483125.txt	TRUE	2018	acute	10	10	Clostridium difficile infection	positive	n/a	goldensyrian	f	42	6 weeks	100	100g	hamster		clindamycin+challenge	clindamycin+challenge	survival	f	t	12	630	100		spores	100	10	50	5	mg/kg	bid	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/29483125	29483125	29483125.txt	TRUE	2018	acute	10	1	Clostridium difficile infection	positive	n/a	goldensyrian	f	42	6 weeks	100	100g	hamster		clindamycin+challenge	clindamycin+challenge	survival	f	t	12	630	100		spores	100								negativecontrol	vancomycin 5 mg/kg	superior	superior		Y	TRUE	0.1
https://pubmed.ncbi.nlm.nih.gov/29483125	29483125	29483125.txt	TRUE	2018	sustained	10	4	Clostridium difficile infection	positive	n/a	goldensyrian	f	42	6 weeks	100	100g	hamster		clindamycin+challenge	clindamycin+challenge	survival	f	t	12	630	100		spores	100	10	50	5	mg/kg	bid	5		vancomycin	Negative Control	superior	superior		Y	TRUE	0.4
https://pubmed.ncbi.nlm.nih.gov/29483125	29483125	29483125.txt	TRUE	2018	sustained	10	1	Clostridium difficile infection	positive	n/a	goldensyrian	f	42	6 weeks	100	100g	hamster		clindamycin+challenge	clindamycin+challenge	survival	f	t	12	630	100		spores	100								negativecontrol	vancomycin 5 mg/kg	superior	superior		Y	TRUE	0.1
https://pubmed.ncbi.nlm.nih.gov/19251726	19251726	19251726.txt	TRUE	2009	acute	8	6	C. difficile disease	positive	n/a	goldensyrian	m	42	6 weeks	99	89-109g	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1.6x10^7	1	5	0.5	mg/kg	bid	5		rep3123	Vancomycin	superior	superior		Y	TRUE	0.75
https://pubmed.ncbi.nlm.nih.gov/19251726	19251726	19251726.txt	TRUE	2009	acute	8	5	C. difficile disease	positive	n/a	goldensyrian	m	42	6 weeks	99	89-109g	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1.6x10^7	1	5	0.5	mg/kg	bid	5		vancomycin	REP3123	inferior	inferior		Y	TRUE	0.625
https://pubmed.ncbi.nlm.nih.gov/19251726	19251726	19251726.txt	TRUE	2009	acute	8	7	C. difficile disease	positive	n/a	goldensyrian	m	42	6 weeks	99	89-109g	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1.6x10^7	10	50	5	mg/kg	bid	5		rep3123	control	superior	superior		Y	TRUE	0.875
https://pubmed.ncbi.nlm.nih.gov/19251726	19251726	19251726.txt	TRUE	2009	acute	8	8	C. difficile disease	positive	n/a	goldensyrian	m	42	6 weeks	99	89-109g	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1.6x10^7	10	50	5	mg/kg	bid	5		vancomycin	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/19251726	19251726	19251726.txt	TRUE	2009	acute	8	0	C. difficile disease	positive	n/a	goldensyrian	m	42	6 weeks	99	89-109g	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1.6x10^7								control	control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/19251726	19251726	19251726.txt	TRUE	2009	sustained	8	5	C. difficile disease	positive	n/a	goldensyrian	m	42	6 weeks	99	89-109g	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1.6x10^7	1	5	0.5	mg/kg	bid	5		rep3123	Vancomycin	superior	superior		Y	TRUE	0.625
https://pubmed.ncbi.nlm.nih.gov/19251726	19251726	19251726.txt	TRUE	2009	sustained	8	5	C. difficile disease	positive	n/a	goldensyrian	m	42	6 weeks	99	89-109g	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1.6x10^7	1	5	0.5	mg/kg	bid	5		vancomycin	REP3123	inferior	inferior		Y	TRUE	0.625
https://pubmed.ncbi.nlm.nih.gov/19251726	19251726	19251726.txt	TRUE	2009	sustained	8	6	C. difficile disease	positive	n/a	goldensyrian	m	42	6 weeks	99	89-109g	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1.6x10^7	10	50	5	mg/kg	bid	5		rep3123	control	superior	superior		Y	TRUE	0.75
https://pubmed.ncbi.nlm.nih.gov/19251726	19251726	19251726.txt	TRUE	2009	sustained	8	0	C. difficile disease	positive	n/a	goldensyrian	m	42	6 weeks	99	89-109g	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1.6x10^7	10	50	5	mg/kg	bid	5		vancomycin	control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/19251726	19251726	19251726.txt	TRUE	2009	sustained	8	0	C. difficile disease	positive	n/a	goldensyrian	m	42	6 weeks	99	89-109g	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1.6x10^7								control	control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33045352	33045352	33045352.txt	TRUE	2020	acute	10	0	Clostridioides difficile infection	positive	n/a	c57bl/6	f	42	6 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	8x10^5	1	6	1	mg/kg	qd	6		metronidazole	control	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33045352	33045352	33045352.txt	TRUE	2020	acute	10	6	Clostridioides difficile infection	positive	n/a	c57bl/6	f	42	6 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	8x10^5	10	60	10	mg/kg	qd	6		metronidazole	vancomycin 10 mg/kg	inferior	NA		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/33045352	33045352	33045352.txt	TRUE	2020	acute	10	10	Clostridioides difficile infection	positive	n/a	c57bl/6	f	42	6 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	8x10^5	10	60	10	mg/kg	qd	6		vancomycin	control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/33045352	33045352	33045352.txt	TRUE	2020	acute	10	2	Clostridioides difficile infection	positive	n/a	c57bl/6	f	42	6 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	8x10^5								control	Negative Control	superior	NA		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/32501140	32501140	32501140.txt	TRUE	2020	acute	20	14	Clostridioides difficile infection	positive	n/a	c57bl/6	f	46	6-7 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	27	r20291	8000	cfu	vegetative	8x10^3								fmt-fd	Positive Control	inferior	NA		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/32501140	32501140	32501140.txt	TRUE	2020	acute	20	11	Clostridioides difficile infection	positive	n/a	c57bl/6	f	46	6-7 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	27	r20291	8000	cfu	vegetative	8x10^3								fmt-g10	Positive Control	inferior	NA		Y	TRUE	0.55
https://pubmed.ncbi.nlm.nih.gov/32501140	32501140	32501140.txt	TRUE	2020	acute	20	12	Clostridioides difficile infection	positive	n/a	c57bl/6	f	46	6-7 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	27	r20291	8000	cfu	vegetative	8x10^3								fmt-g80	Positive Control	inferior	NA		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/32501140	32501140	32501140.txt	TRUE	2020	acute	10	2	Clostridioides difficile infection	positive	n/a	c57bl/6	f	46	6-7 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	27	r20291	8000	cfu	vegetative	8x10^3								negativecontrol	FMT-G10	inferior	NA		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/23939887/	23939887	23939887.txt	TRUE	2013	acute	10	10	Clostridium difficile	positive	n/a	goldensyrian	m	49	6-8 weeks		N/A	hamster		clindamycin+challenge	clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	100	1000000		10^6	cfuofspores	qd	1		m3,antcdstrain	control				Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23939887/	23939887	23939887.txt	TRUE	2013	acute	10	10	Clostridium difficile	positive	n/a	goldensyrian	m	49	6-8 weeks		N/A	hamster		clindamycin+challenge	clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	100	1000000		10^6	cfuofspores	qd	1		t7,antcdstrain	control				Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23939887/	23939887	23939887.txt	TRUE	2013	acute	2	0	Clostridium difficile	positive	n/a	goldensyrian	m	49	6-8 weeks		N/A	hamster		clindamycin+challenge	clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	100								control					Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/23939887/	23939887	23939887.txt	TRUE	2013	sustained	10	9	Clostridium difficile	positive	n/a	goldensyrian	m	49	6-8 weeks		N/A	hamster		clindamycin+challenge	clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	100	1000000	1000000	10^6	cfuofspores	qd	1		m3,antcdstrain	control				Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/23939887/	23939887	23939887.txt	TRUE	2013	sustained	10	8	Clostridium difficile	positive	n/a	goldensyrian	m	49	6-8 weeks		N/A	hamster		clindamycin+challenge	clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	100	1000000	1000000	10^6	cfuofspores	qd	1		t7,antcdstrain	control				Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/23939887/	23939887	23939887.txt	TRUE	2013	sustained	2	0	Clostridium difficile	positive	n/a	goldensyrian	m	49	6-8 weeks		N/A	hamster		clindamycin+challenge	clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	100								control					Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	4	4	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5	10	50	10	mg/kg	qd	5		actoxumab-bezlotoxumab	actoxumab-bezlotoxumab	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	4	4	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5	2	10	2	mg/kg	qd	5		actoxumab-bezlotoxumab	actoxumab-bezlotoxumab	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	5	4	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	t	27	uk1	100000		spores	10^5	5	25	5	mg/kg	qd	5		actoxumab-bezlotoxumab	Negative Control	superior	NA		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	4	4	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5	50	250	50	mg/kg	qd	5		actoxumab-bezlotoxumab	actoxumab-bezlotoxumab	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	6	6	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5	50	50	50	mg/kg	qd	1		actoxumab-bezlotoxumab	Negative Control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	5	5	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	t	27	uk1	100000		spores	10^5	50	50	50	mg/kg	qd	1		actoxumab-bezlotoxumab	N297Q mutant actoxumab-bezlotoxumab	inferior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	6	6	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5	50	50	50	mg/kg	qd	1		n297qmutantactoxumab-bezlotoxumab	N297Q mutant actoxumab-bezlotoxumab	inferior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	10	2	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5								control	actoxumab-bezlotoxumab	superior	NA		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	15	8	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5								control	Negative Control	superior	NA		Y	TRUE	0.5333333333333333
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	10	1	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	t	27	uk1	100000		spores	10^5								control	Negative Control	superior	NA		Y	TRUE	0.1
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	sustained	4	4	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5	10	50	10	mg/kg	qd	5		actoxumab-bezlotoxumab	actoxumab-bezlotoxumab	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	sustained	4	4	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5	2	10	2	mg/kg	qd	5		actoxumab-bezlotoxumab	actoxumab-bezlotoxumab	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	sustained	5	4	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	t	27	uk1	100000		spores	10^5	5	25	5	mg/kg	qd	5		actoxumab-bezlotoxumab	Negative Control	superior	NA		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	sustained	6	6	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5	50	50	50	mg/kg	qd	1		actoxumab-bezlotoxumab	Negative Control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	sustained	5	5	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	t	27	uk1	100000		spores	10^5	50	50	50	mg/kg	qd	1		actoxumab-bezlotoxumab	N297Q mutant actoxumab-bezlotoxumab	inferior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	sustained	6	6	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5	50	50	50	mg/kg	qd	1		n297qmutantactoxumab-bezlotoxumab	N297Q mutant actoxumab-bezlotoxumab	inferior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	sustained	4	4	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5	50	250	50	mg/kg	qd	5		actoxumab-bezlotoxumab	actoxumab-bezlotoxumab	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	sustained	10	2	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge+20dayrecovery+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5								control	actoxumab-bezlotoxumab	superior	NA		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	sustained	15	8	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	p	27	uk1	100000		spores	10^5								control	Negative Control	superior	NA		Y	TRUE	0.5333333333333333
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	sustained	10	1	Clostridium difficile infection	positive	n/a	c57bl/6	n/a	49	6-8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	C. difficile spores	survival	f	t	27	uk1	100000		spores	10^5								control	Negative Control	superior	NA		Y	TRUE	0.1
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	6	0		positive	n/a	cd1	n/a	49	6-8 weeks		N/A	mouse		25ngeachtcdaandtcdb+ip	C. difficile spores	survival	f	p	87	vpi10463	5	ug		2.5 TcdA + 2.5 TcdB	0.1	0.1	0.1	mg/kg	qd	1		actoxumab-bezlotoxumab	Negative Control	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	6	0		positive	n/a	cd1	n/a	49	6-8 weeks		N/A	mouse		25ngeachtcdaandtcdb+ip	C. difficile spores	survival	f	p	87	vpi10463	5	ug		2.5 TcdA + 2.5 TcdB	1	1	1	mg/kg	qd	1		actoxumab-bezlotoxumab	Negative Control	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	6	2		positive	n/a	cd1	n/a	49	6-8 weeks		N/A	mouse		25ngeachtcdaandtcdb+ip	C. difficile spores	survival	f	p	87	vpi10463	5	ug		2.5 TcdA + 2.5 TcdB	10	10	10	mg/kg	qd	1		actoxumab-bezlotoxumab	Negative Control	superior	NA		Y	TRUE	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25486992	25486992	25486992.txt	TRUE	2015	acute	6	0		positive	n/a	cd1	n/a	49	6-8 weeks		N/A	mouse		25ngeachtcdaandtcdb+ip	C. difficile spores	survival	f	p	87	vpi10463	5	ug		2.5 TcdA + 2.5 TcdB								control	Negative Control	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/26568840	26568840	26568840.txt	TRUE	2015	acute	6	5	C. difficile infection (CDI)	positive	n/a	c57bl/6j	f	49	6-8 weeks	19	18-19g	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	200000	cfu		2x10^5	100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	50 mg/kg QD + 50 mg/kg QD for 10 days	vancomycin+metronidazole	infected control	inferior	inferior		Y	TRUE	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/26568840	26568840	26568840.txt	TRUE	2015	acute	6	4	C. difficile infection (CDI)	positive	n/a	c57bl/6j	f	49	6-8 weeks	19	18-19g	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	200000	cfu		2x10^5	50	500	50	mg/kg	qd	10		metronidazole	infected control	inferior	inferior		Y	TRUE	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26568840	26568840	26568840.txt	TRUE	2015	acute	6	6	C. difficile infection (CDI)	positive	n/a	c57bl/6j	f	49	6-8 weeks	19	18-19g	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	200000	cfu		2x10^5	50	500	50	mg/kg	qd	10		vancomycin	infected control	equal	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/26568840	26568840	26568840.txt	TRUE	2015	acute	9	4	C. difficile infection (CDI)	positive	n/a	c57bl/6j	f	49	6-8 weeks	19	18-19g	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	200000	cfu		2x10^5								infectedcontrol	Positive Control	inferior	inferior		Y	TRUE	0.4444444444444444
https://pubmed.ncbi.nlm.nih.gov/26568840	26568840	26568840.txt	TRUE	2015	sustained	6	4	C. difficile infection (CDI)	positive	n/a	c57bl/6j	f	49	6-8 weeks	19	18-19g	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	200000	cfu		2x10^5	100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	50 mg/kg QD + 50 mg/kg QD for 10 days	vancomycin+metronidazole	infected control	inferior	inferior		Y	TRUE	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26568840	26568840	26568840.txt	TRUE	2015	sustained	6	4	C. difficile infection (CDI)	positive	n/a	c57bl/6j	f	49	6-8 weeks	19	18-19g	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	200000	cfu		2x10^5	50	500	50	mg/kg	qd	10		metronidazole	infected control	inferior	inferior		Y	TRUE	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26568840	26568840	26568840.txt	TRUE	2015	sustained	6	3	C. difficile infection (CDI)	positive	n/a	c57bl/6j	f	49	6-8 weeks	19	18-19g	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	200000	cfu		2x10^5	50	500	50	mg/kg	qd	10		vancomycin	infected control	equal	inferior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/26568840	26568840	26568840.txt	TRUE	2015	sustained	9	4	C. difficile infection (CDI)	positive	n/a	c57bl/6j	f	49	6-8 weeks	19	18-19g	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	200000	cfu		2x10^5								infectedcontrol	Positive Control	inferior	inferior		Y	TRUE	0.4444444444444444
https://pubmed.ncbi.nlm.nih.gov/31849218	31849218	31849218.txt	TRUE	2020	acute	10	5	Clostridium difficile infection	positive	n/a	c57/b6	f	49	6-8 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	8600000	cfu		8.6x10^6	20	140	20	mg/kg	qd	7		metronidazole	Negative Control	superior	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/31849218	31849218	31849218.txt	TRUE	2020	acute	10	10	Clostridium difficile infection	positive	n/a	c57/b6	f	49	6-8 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	8600000	cfu		8.6x10^6	20	140	20	mg/kg	qd	7		vancomycin	Negative Control	superior	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/31849218	31849218	31849218.txt	TRUE	2020	acute	10	3	Clostridium difficile infection	positive	n/a	c57/b6	f	49	6-8 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	8600000	cfu		8.6x10^6								vehiclecontrol	vancomycin 20mg/kg	superior	inferior		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/31849218	31849218	31849218.txt	TRUE	2020	sustained	10	5	Clostridium difficile infection	positive	n/a	c57/b6	f	49	6-8 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	8600000	cfu		8.6x10^6	20	140	20	mg/kg	qd	7		metronidazole	Negative Control	superior	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/31849218	31849218	31849218.txt	TRUE	2020	sustained	10	3	Clostridium difficile infection	positive	n/a	c57/b6	f	49	6-8 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	8600000	cfu		8.6x10^6	20	140	20	mg/kg	qd	7		vancomycin	Negative Control	superior	equivalent		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/31849218	31849218	31849218.txt	TRUE	2020	sustained	10	3	Clostridium difficile infection	positive	n/a	c57/b6	f	49	6-8 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	8600000	cfu		8.6x10^6								vehiclecontrol	vancomycin 20mg/kg	superior	inferior		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	acute	10	10	Clostridium difficile	positive	spf	c57bl/6	n/a	56	7-9 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	10^6	20	100	10	mg/kg	bid	5		vancomycin	vehicle control	superior	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	acute	10	10	Clostridium difficile	positive	spf	c57bl/6	n/a	56	7-9 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	1000000	cfu	vegetative	10^6	50	100	50	mg/kg	qd	2		actoxumab-bezlotoxumab	vehicle control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	acute	10	3	Clostridium difficile	positive	spf	c57bl/6	n/a	56	7-9 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	10^6								vehiclecontrol	vancomycin 20 mg/kg	superior	inferior		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	sustained	10	2	Clostridium difficile	positive	spf	c57bl/6	n/a	56	7-9 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	10^6	20	100	10	mg/kg	bid	5		vancomycin	vehicle control	superior	inferior		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	sustained	10	9	Clostridium difficile	positive	spf	c57bl/6	n/a	56	7-9 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	1000000	cfu	vegetative	10^6	50	100	50	mg/kg	qd	2		actoxumab-bezlotoxumab	vehicle control	superior	superior		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	sustained	10	3	Clostridium difficile	positive	spf	c57bl/6	n/a	56	7-9 weeks		N/A	mouse		cefoperazone+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	10^6								vehiclecontrol	vancomycin 20 mg/kg	superior	inferior		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	acute	8	4	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse	aninhibitorofpyruvate:ferredoxinoxidoreductase(pfor)	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4	20	100	20	mg/kg	qd	5		amixicile	Negative Control	superior	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	acute	8	2	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4	20	100	20	mg/kg	qd	5		nitazoxanide	Negative Control	superior	NA		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	acute	8	8	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4	20	100	20	mg/kg	qd	5		vancomycin	Negative Control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	acute	8	2	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4	20	100	20	mg/kg	qd	5		vpc161183	Negative Control	superior	NA		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	acute	8	2	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4								control	Negative Control	superior	NA		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	sustained	8	4	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse	aninhibitorofpyruvate:ferredoxinoxidoreductase(pfor)	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4	20	100	20	mg/kg	qd	5		amixicile	Negative Control	superior	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	sustained	8	2	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4	20	100	20	mg/kg	qd	5		nitazoxanide	Negative Control	superior	NA		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	sustained	8	1	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4	20	100	20	mg/kg	qd	5		vancomycin	Negative Control	superior	NA		Y	TRUE	0.125
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	sustained	8	2	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4	20	100	20	mg/kg	qd	5		vpc161183	Negative Control	superior	NA		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	sustained	8	2	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	10000	cfu		10^4								control	Negative Control	superior	NA		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	16	10	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	50000			10^4 to 10^5	20	100	20	mg/kg	qd	5		nitazoxanide	Positive Control	inferior	inferior		Y	TRUE	0.625
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	16	16	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	50000			10^4 to 10^5	20	100	20	mg/kg	qd	5		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	16	10	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	50000			10^4 to 10^5	20	100	20	mg/kg	qd	5		nitazoxanide	Negative Control	equivalent	superior		Y	TRUE	0.625
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	16	5	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	50000			10^4 to 10^5	20	100	20	mg/kg	qd	5		vancomycin	Negative Control	superior	equivalent		Y	TRUE	0.3125
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	acute	10	7	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse	aninhibitorofpyruvate:ferredoxinoxidoreductase(pfor)	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	20	100	20	mg/kg	qd	5		amixicile	Negative Control	superior	superior		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	acute	6	2	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	20	100	20	mg/kg	qd	5		amixicile+vancomycin	Negative Control	superior	NA		Y	TRUE	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	acute	10	8	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	20	100	20	mg/kg	qd	5		fidaxomicin	Negative Control	superior	NA		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	acute	10	8	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	20	100	20	mg/kg	qd	5		vancomycin	Negative Control	superior	NA		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	acute	10	0	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5								control	Negative Control	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	sustained	10	7	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse	aninhibitorofpyruvate:ferredoxinoxidoreductase(pfor)	vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	20	100	20	mg/kg	qd	5		amixicile	Negative Control	superior	superior		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	sustained	6	1	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	20	100	20	mg/kg	qd	5		amixicile+vancomycin	Negative Control	superior	NA		Y	TRUE	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	sustained	10	2	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	20	100	20	mg/kg	qd	5		fidaxomicin	Negative Control	superior	NA		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	sustained	10	3	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	20	100	20	mg/kg	qd	5		vancomycin	Negative Control	superior	NA		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/22585229	22585229	22585229.txt	TRUE	2012	sustained	10	0	C. difficile disease	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5								control	Negative Control	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	8	2	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5								control	Positive Control	equivalent	inferior		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	8	8	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	50	50	mg/kg	qd	1		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	8	8	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	100	50	mg/kg	qd	2		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	8	8	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	150	50	mg/kg	qd	3		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	8	7	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	250	50	mg/kg	qd	5		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	0.875
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	8	2	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5								control	Positive Control	equivalent	inferior		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	8	4	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	50	50	mg/kg	qd	1		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	8	2	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	100	50	mg/kg	qd	2		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	8	1	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	150	50	mg/kg	qd	3		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	0.125
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	8	0	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	50	250	50	mg/kg	qd	5		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	6	2	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5								vancomycin	Positive Control	equivalent	inferior		Y	TRUE	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	6	6	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	20	100	20	mg/kg	qd	5		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	6	6	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	20	200	20	mg/kg	qd	10		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	6	2	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5								vancomycin	Positive Control	equivalent	inferior		Y	TRUE	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	6	2	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	20	100	20	mg/kg	qd	5		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	6	0	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	20	200	20	mg/kg	qd	10		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	6	5	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	20	100	20	mg/kg	qd	5		metronidazole	Positive Control	equivalent	inferior		Y	TRUE	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	acute	6	6	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	20	100	20	mg/kg	qd	5		fidaxomicin	Positive Control	equivalent	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	6	5	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	20	100	20	mg/kg	qd	5		metronidazole	Positive Control	equivalent	inferior		Y	TRUE	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/23147742	23147742	23147742.txt	TRUE	2012	sustained	6	1	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000			10^5	20	100	20	mg/kg	qd	5		fidaxomicin	Positive Control	equivalent	inferior		Y	TRUE	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/23217055	23217055	23217055.txt	TRUE	2012	acute	6	1	C. difficile	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	50	150	50	mg/kg	qd	3		atl370	Positive Control	inferior	inferior		Y	TRUE	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/23217055	23217055	23217055.txt	TRUE	2012	acute	6	6	C. difficile	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	50	150	50	mg/kg	qd	3		vancomycin	Positive Control	equivalent	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23217055	23217055	23217055.txt	TRUE	2012	acute	6	6	C. difficile	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	50	150	50	mg/kg	qd	3		vancomycin+atl370	vancomycin	inferior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/23217055	23217055	23217055.txt	TRUE	2012	sustained	6	1	C. difficile	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	50	150	50	mg/kg	qd	3		atl370	Negative Control	inferior	inferior		Y	TRUE	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/23217055	23217055	23217055.txt	TRUE	2012	sustained	6	0	C. difficile	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	50	150	50	mg/kg	qd	3		vancomycin	Negative Control	superior	inferior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/23217055	23217055	23217055.txt	TRUE	2012	sustained	6	2	C. difficile	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu		10^5	50	150	50	mg/kg	qd	3		vancomycin+atl370	vancomycin + ATL370	inferior	inferior		Y	TRUE	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/26832756	26832756	26832756.txt	TRUE	2016	acute	19	19	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	10^5	20	100	20	mg/kg	qd	5		vancomycin	vehicle control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/26832756	26832756	26832756.txt	TRUE	2016	acute	44	6	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	10^5								vehiclecontrol	vancomycin 20 mg/kg	superior	superior		Y	TRUE	0.13636363636363635
https://pubmed.ncbi.nlm.nih.gov/26832756	26832756	26832756.txt	TRUE	2016	sustained	19	7	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	10^5	20	100	20	mg/kg	qd	5		vancomycin	vehicle control	superior	superior		Y	TRUE	0.3684210526315789
https://pubmed.ncbi.nlm.nih.gov/26832756	26832756	26832756.txt	TRUE	2016	sustained	44	6	Clostridium difficile infection	positive	n/a	c57bl/6	m	56	8 weeks		N/A	mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	10^5								vehiclecontrol	vancomycin 20 mg/kg	superior	superior		Y	TRUE	0.13636363636363635
https://pubmed.ncbi.nlm.nih.gov/29109161	29109161	29109161.txt	TRUE	2017	acute	5	3	Clostridium difficile infection	positive	n/a	c57bl/6	f	56	8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	10^6	20	100	20	mg/kg	qd	5		vancomycin	pbs control	superior	NA		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/29109161	29109161	29109161.txt	TRUE	2017	acute	7	0	Clostridium difficile infection	positive	n/a	c57bl/6	f	56	8 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge		cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	10^6								pbscontrol	vancomycin 20mg/kg	inferior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	acute	14	13	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	1.8	7.2	0.6	mg/kg	tid	4		it2s4	Negative Control	superior	superior		Y	TRUE	0.9285714285714286
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	acute	17	17	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	36	144	12	mg/kg	tid	4		it2s4	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	acute	12	12	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	900	3600	300	mg/kg	tid	4		it2s4	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	acute	18	18	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	50	250	50	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	acute	14	14	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	18	72	6	mg/kg	tid	4		it2s4	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	acute	25	25	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	180	720	60	mg/kg	tid	4		it2s4	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	sustained	14	6	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	1.8	7.2	0.6	mg/kg	tid	4		it2s4	IT2S4	eqivalent	equivalent		Y	TRUE	0.42857142857142855
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	sustained	17	7	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	36	144	12	mg/kg	tid	4		it2s4	vancomycin	eqivalent	equivalent		Y	TRUE	0.4117647058823529
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	sustained	12	4	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	900	3600	300	mg/kg	tid	4		it2s4	vancomycin	eqivalent	equivalent		Y	TRUE	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	sustained	18	7	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	50	250	50	mg/kg	qd	5		vancomycin	IT2S4	eqivalent	equivalent		Y	TRUE	0.3888888888888889
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	sustained	14	11	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	18	72	6	mg/kg	tid	4		it2s4	vancomycin	eqivalent	equivalent		Y	TRUE	0.7857142857142857
https://pubmed.ncbi.nlm.nih.gov/30482680	30482680	30482680.txt	TRUE	2018	sustained	25	9	C. difficile disease	positive	n/a	c57bl/6j	f	63	8-10 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	5x10^5	180	720	60	mg/kg	tid	4		it2s4	vancomycin	eqivalent	equivalent		Y	TRUE	0.36
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	107	50	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	0.2	1	0.1	mg/kg	bid	5		cadazolid	vancomycin	equivalent	equivalent		Y	TRUE	0.4672897196261682
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	11	1	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	0.2	1	0.1	mg/kg	bid	5		vancomycin	Cadazolid	equivalent	equivalent		Y	TRUE	0.09090909090909091
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	114	110	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	2	10	1	mg/kg	bid	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.9649122807017544
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	17	15	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	2	10	1	mg/kg	bid	5		vancomycin	Cadazolid	equivalent	equivalent		Y	TRUE	0.8823529411764706
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	107	107	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	20	100	10	mg/kg	bid	5		cadazolid	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	11	11	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	20	100	10	mg/kg	bid	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	137	24	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5								cadazolidcontrol	Negative Control	superior	superior		Y	TRUE	0.17518248175182483
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	acute	16	2	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5								vancomycincontrol	Negative Control	superior	superior		Y	TRUE	0.125
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	107	43	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	0.2	1	0.1	mg/kg	bid	5		cadazolid	vancomycin	equivalent	equivalent		Y	TRUE	0.40186915887850466
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	11	1	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	0.2	1	0.1	mg/kg	bid	5		vancomycin	Cadazolid	equivalent	equivalent		Y	TRUE	0.09090909090909091
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	114	105	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	2	10	1	mg/kg	bid	5		cadazolid	vancomycin	equivalent	equivalent		Y	TRUE	0.9210526315789473
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	17	12	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	2	10	1	mg/kg	bid	5		vancomycin	Cadazolid	equivalent	equivalent		Y	TRUE	0.7058823529411765
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	107	94	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	20	100	10	mg/kg	bid	5		cadazolid	Negative Control	superior	superior		Y	TRUE	0.8785046728971962
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	11	9	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5	20	100	10	mg/kg	bid	5		vancomycin	Negative Control	superior	superior		Y	TRUE	0.8181818181818182
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	137	17	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5								cadazolidcontrol	Negative Control	superior	superior		Y	TRUE	0.12408759124087591
https://pubmed.ncbi.nlm.nih.gov/24277020	24277020	24277020.txt	TRUE	2014	sustained	16	2	C. difficile disease	positive	n/a	c57bl/6	f	70	8-12 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10^5								vancomycincontrol	Negative Control	superior	superior		Y	TRUE	0.125
https://pubmed.ncbi.nlm.nih.gov/18848941	18848941	18848941.txt	TRUE	2008	acute	12	12	C. difficile disease	positive	n/a	c57bl/6	f	63	9 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		10^4	50	50	50	mg/kg	qd	1		vancomycin	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/18848941	18848941	18848941.txt	TRUE	2008	acute	12	6	C. difficile disease	positive	n/a	c57bl/6	f	63	9 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		10^4								control	control	superior	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/18848941	18848941	18848941.txt	TRUE	2008	sustained	12	5	C. difficile disease	positive	n/a	c57bl/6	f	63	9 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		10^4	50	50	50	mg/kg	qd	1		vancomycin	control	superior	superior		Y	TRUE	0.4166666666666667
https://pubmed.ncbi.nlm.nih.gov/18848941	18848941	18848941.txt	TRUE	2008	sustained	12	6	C. difficile disease	positive	n/a	c57bl/6	f	63	9 weeks		N/A	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		10^4								control	control	superior	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/33202811	33202811	33202811.txt	TRUE	2020	acute	9	8	Clostridioides difficile	positive	n/a	goldensyrian	f		adult	95	80-110g	hamster		clindamycin+challenge		cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	5x10^3	1000000	1000000	10^6	spores	qd	1		pcd130+027	Negative Control	superior	superior		Y	TRUE	0.8888888888888888
https://pubmed.ncbi.nlm.nih.gov/33202811	33202811	33202811.txt	TRUE	2020	acute	9	8	Clostridioides difficile	positive	n/a	goldensyrian	f		adult	95	80-110g	hamster		clindamycin+challenge		cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	5x10^3	1000000	1000000	10^6	spores	qd	1		pcd182+027	Negative Control	superior	superior		Y	TRUE	0.8888888888888888
https://pubmed.ncbi.nlm.nih.gov/33202811	33202811	33202811.txt	TRUE	2020	acute	8	0	Clostridioides difficile	positive	n/a	goldensyrian	f		adult	95	80-110g	hamster		clindamycin+challenge		cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	5x10^3								negativecontrol	PCD130 + 027	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33202811	33202811	33202811.txt	TRUE	2020	sustained	9	5	Clostridioides difficile	positive	n/a	goldensyrian	f		adult	95	80-110g	hamster		clindamycin+challenge		cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	5x10^3	1000000	1000000	10^6	spores	qd	1		pcd130+027	Negative Control	superior	superior		Y	TRUE	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/33202811	33202811	33202811.txt	TRUE	2020	sustained	9	8	Clostridioides difficile	positive	n/a	goldensyrian	f		adult	95	80-110g	hamster		clindamycin+challenge		cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	5x10^3	1000000	1000000	10^6	spores	qd	1		pcd182+027	Negative Control	superior	superior		Y	TRUE	0.8888888888888888
https://pubmed.ncbi.nlm.nih.gov/33202811	33202811	33202811.txt	TRUE	2020	sustained	8	0	Clostridioides difficile	positive	n/a	goldensyrian	f		adult	95	80-110g	hamster		clindamycin+challenge		cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	5x10^3								negativecontrol	PCD130 + 027	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	acute	33	32	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	20	100	10	mg/kg	bid	5		cb-183,315	Negative Control	superior	superior		Y	TRUE	0.9696969696969697
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	acute	24	24	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	20	100	10	mg/kg	bid	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	acute	32	32	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	4	20	2	mg/kg	bid	5		cb-183,315	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	acute	24	24	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	4	20	2	mg/kg	bid	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	acute	16	16	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	50	250	25	mg/kg	bid	5		cb-183,315	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	acute	16	16	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	50	250	25	mg/kg	bid	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	acute	15	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20								control	Negative Control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	sustained	33	25	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	20	100	10	mg/kg	bid	5		cb-183,315	vancomycin	inferior	inferior		Y	TRUE	0.7575757575757576
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	sustained	24	21	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	20	100	10	mg/kg	bid	5		vancomycin	CB-183,315	superior	superior		Y	TRUE	0.875
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	sustained	32	16	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	4	20	2	mg/kg	bid	5		cb-183,315	vancomycin	inferior	inferior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	sustained	24	13	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	4	20	2	mg/kg	bid	5		vancomycin	CB-183,315	superior	superior		Y	TRUE	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	sustained	16	13	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	50	250	25	mg/kg	bid	5		cb-183,315	vancomycin	inferior	inferior		Y	TRUE	0.8125
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	sustained	16	11	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20	50	250	25	mg/kg	bid	5		vancomycin	CB-183,315	superior	superior		Y	TRUE	0.6875
https://pubmed.ncbi.nlm.nih.gov/22802252	22802252	22802252.txt	TRUE	2012	sustained	15	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	12	atcc43596	20		spores	20								control	Negative Control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25993059	25993059	25993059.txt	TRUE	2015	acute	8	8	Clostridium difficile	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	20	0.5	2.5	0.5	mg/kg	qd	5		surotomycin	vehicle control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25993059	25993059	25993059.txt	TRUE	2015	acute	8	8	Clostridium difficile	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	20	0.5	2.5	0.5	mg/kg	qd	5		vancomycin	vehicle control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25993059	25993059	25993059.txt	TRUE	2015	acute	5	0	Clostridium difficile	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	20								vehiclecontrol	vancomycin 0.5 mg/kg	inferior	inferior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25993059	25993059	25993059.txt	TRUE	2015	sustained	8	8	Clostridium difficile	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	20	0.5	2.5	0.5	mg/kg	qd	5		surotomycin	vancomycin 0.5 mg/kg	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25993059	25993059	25993059.txt	TRUE	2015	sustained	8	2	Clostridium difficile	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	20	0.5	2.5	0.5	mg/kg	qd	5		vancomycin	vehicle control	superior	superior		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/25993059	25993059	25993059.txt	TRUE	2015	sustained	5	0	Clostridium difficile	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	20								vehiclecontrol	vancomycin 0.5 mg/kg	inferior	inferior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/24514098	24514098	24514098.txt	TRUE	2014	acute	5	4	C. difficile disease	positive	n/a	goldensyrian	m		N/A	98	98g	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge		cumulativemortality	t	t	53	b1	53		spores	53	3.12	12.48	1.56	mg/kg	bid	4		kibdelomycin	vancomycin	inferior	NA		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/24514098	24514098	24514098.txt	TRUE	2014	acute	5	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	98	98g	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge		cumulativemortality	t	t	53	b1	53		spores	53	25	100	12.5	mg/kg	bid	4		kibdelomycin	vehicle control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	24514098	24514098.txt	TRUE	2014	acute	5	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	98	98g	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge		cumulativemortality	t	t	53	b1	53		spores	53	12.5	50	6.25	mg/kg	bid	4		kibdelomycin	vancomycin	inferior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	24514098	24514098.txt	TRUE	2014	acute	5	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	98	98g	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge		cumulativemortality	t	t	53	b1	53		spores	53	12.5	50	6.25	mg/kg	bid	4		vancomycin	vehicle control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	24514098	24514098.txt	TRUE	2014	sustained	5	4	C. difficile disease	positive	n/a	goldensyrian	m		N/A	98	98g	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge		cumulativemortality	t	t	53	b1	53		spores	53	3.12	12.48	1.56	mg/kg	bid	4		kibdelomycin	vancomycin	inferior	NA		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/24514098	24514098	24514098.txt	TRUE	2014	sustained	5	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	98	98g	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge		cumulativemortality	t	t	53	b1	53		spores	53	25	100	12.5	mg/kg	bid	4		kibdelomycin	untreated control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	24514098	24514098.txt	TRUE	2014	sustained	5	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	98	98g	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge		cumulativemortality	t	t	53	b1	53		spores	53	12.5	50	6.25	mg/kg	bid	4		kibdelomycin	vancomycin	inferior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	24514098	24514098.txt	TRUE	2014	sustained	5	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	98	98g	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge		cumulativemortality	t	t	53	b1	53		spores	53	12.5	50	6.25	mg/kg	bid	4		vancomycin	untreated control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	50	12	C. difficile disease	positive	n/a	swisswebster	n/a		N/A		N/A	mouse	antibody	toxinaintraperitoneally		survival	f	p	87	vpi10463	100	ngtoxina		100			100 to 250	ug				1b11	Negative Control	equivalent	NA		Y	TRUE	0.24
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	70	52	C. difficile disease	positive	n/a	swisswebster	n/a		N/A		N/A	mouse	antibody	toxinaintraperitoneally		survival	f	p	87	vpi10463	100	ngtoxina		100			100 to 250	ug			100 to 250 ug	3h2	Negative Control	superior	NA		Y	TRUE	0.7428571428571429
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	90	60	C. difficile disease	positive	n/a	swisswebster	n/a		N/A		N/A	mouse	antibody	toxinaintraperitoneally		survival	f	p	87	vpi10463	100	ngtoxina		100			100 to 250	ug			100 to 250 ug	cda1	Negative Control	superior	NA		Y	TRUE	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	105	24	C. difficile disease	positive	n/a	swisswebster	n/a		N/A		N/A	mouse	antibody	toxinaintraperitoneally		survival	f	p	87	vpi10463	100	ngtoxina		100								control-irrelevanthumab	Negative Control	equivalent	NA		Y	TRUE	0.22857142857142856
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	17	3	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	140	cfu	spores	140			10 to 50	mg/kg	qd	4	10 to 50 mg/kg for 4 days	mdx1388	Negative Control	superior	superior		Y	TRUE	0.17647058823529413
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	42	23	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	140	cfu	spores	140	50	200	50	mg/kg	qd	4		cda1	Negative Control	superior	superior		Y	TRUE	0.5476190476190477
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	65	61	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	140	cfu	spores	140			50 CDA1 + 10 to 50 MDX1388	mg/kg	qd	4	50 mg/kg QD CDA1 + 10 to 50 mg/kg QD MDX1388 for 4 days	cda1+mdx1388	Negative Control	superior	superior		Y	TRUE	0.9384615384615385
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	55	3	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	140	cfu	spores	140								control	Negative Control	superior	superior		Y	TRUE	0.05454545454545454
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	sustained	17	0	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	140	cfu	spores	140			10 to 50	mg/kg	qd	4	10 to 50 mg/kg for 4 days	mdx1388	Negative Control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	sustained	42	2	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	140	cfu	spores	140	50	200	50	mg/kg	qd	4		cda1	Negative Control	superior	superior		Y	TRUE	0.047619047619047616
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	sustained	65	36	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	140	cfu	spores	140			50 CDA1 + 10 to 50 MDX1388	mg/kg	qd	4		cda1+mdx1388	Negative Control	superior	superior		Y	TRUE	0.5538461538461539
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	sustained	55	0	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge		cumulativemortality	f	p	87	vpi10463	140	cfu	spores	140								control	Negative Control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	acute	10	10	Clostridium difficile	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	680	20	100	10	mg/kg	bid	5		vancomycin	vehicle control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	acute	10	5	Clostridium difficile	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	p	12	630	680	cfu	spores	680	50	200	50	mg/kg	qd	4		actoxumab-bezlotoxumab	vehicle control	superior	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	acute	10	0	Clostridium difficile	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	680								vehiclecontrol	vancomycin 20 mg/kg	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	sustained	10	0	Clostridium difficile	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	680	20	100	10	mg/kg	bid	5		vancomycin	vehicle control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	sustained	10	4	Clostridium difficile	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	p	12	630	680	cfu	spores	680	50	200	50	mg/kg	qd	4		actoxumab-bezlotoxumab	vehicle control	superior	superior		Y	TRUE	0.4
https://pubmed.ncbi.nlm.nih.gov/27527088	27527088	27527088.txt	TRUE	2016	sustained	10	0	Clostridium difficile	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	680								vehiclecontrol	vancomycin 20 mg/kg	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	15	4	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge+vancomycin		cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	140000	20	80	20	mg/kg	qd	4		mdx1388	Negative Control	superior	superior		Y	TRUE	0.26666666666666666
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	22	15	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge+vancomycin		cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	140000	80	320	60 CDA1 + 20 MDX1388	mg/kg	qd	4	60 mg/kg QD CDA1 + 20 mg/kg QD MDX1388 for 4 days	cda1+mdx1388	Negative Control	superior	superior		Y	TRUE	0.6818181818181818
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	86	48	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge+vancomycin		cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	140000	60	240	60	mg/kg	qd	4		cda1	Negative Control	superior	superior		Y	TRUE	0.5581395348837209
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	acute	82	31	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge+vancomycin		cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	140000								control	Negative Control	superior	superior		Y	TRUE	0.3780487804878049
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	sustained	15	4	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge+vancomycin		cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	140000	20	80	20	mg/kg	qd	4		mdx1388	Negative Control	superior	superior		Y	TRUE	0.26666666666666666
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	sustained	22	15	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge+vancomycin		cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	140000	80	320	60 CDA1 + 20 MDX1388	mg/kg	qd	4	60 mg/kg QD CDA1 + 20 mg/kg QD MDX1388 for 4 days	cda1+mdx1388	Negative Control	superior	superior		Y	TRUE	0.6818181818181818
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	sustained	86	28	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge+vancomycin		cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	140000	60	240	60	mg/kg	qd	4		cda1	Negative Control	superior	superior		Y	TRUE	0.32558139534883723
https://pubmed.ncbi.nlm.nih.gov/16966409	16966409	16966409.txt	TRUE	2006	sustained	82	18	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	75	70-80g	hamster		clindamycin+challenge+vancomycin		cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	140000								control	Negative Control	superior	superior		Y	TRUE	0.21951219512195122
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	2	10	1	mg/kg	bid	5		fidaxomicin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	3	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	2	10	1	mg/kg	bid	5		fidaxomicin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	20	100	10	mg/kg	bid	5		fidaxomicin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	0	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	20	100	10	mg/kg	bid	5		fidaxomicin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	20	100	10	mg/kg	bid	5		vancomycin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	0	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	20	100	10	mg/kg	bid	5		vancomycin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	25	125	12.5	mg/kg	bid	5		smt19969	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	25	125	12.5	mg/kg	bid	5		smt19969	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	5	25	2.5	mg/kg	bid	5		fidaxomicin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	4	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	5	25	2.5	mg/kg	bid	5		fidaxomicin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	0.4
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	50	250	25	mg/kg	bid	5		fidaxomicin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	0	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	50	250	25	mg/kg	bid	5		fidaxomicin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	50	250	25	mg/kg	bid	5		smt19969	vehicle control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	8	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350	50	250	25	mg/kg	bid	5		smt19969	vehicle control	superior	superior		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	0	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350								vehiclecontrol	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	0	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	~100-350								vehiclecontrol	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350	2	10	1	mg/kg	bid	5		fidaxomicin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	9	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350	2	10	1	mg/kg	bid	5		fidaxomicin	SMT19969 12.5 mg/kg BID	eqivalent	eqivalent		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350	20	100	10	mg/kg	bid	5		vancomycin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	1	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350	20	100	10	mg/kg	bid	5		vancomycin	vehicle control	superior	superior		Y	TRUE	0.1
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350	25	125	12.5	mg/kg	bid	5		smt19969	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	9	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350	25	125	12.5	mg/kg	bid	5		smt19969	vehicle control	superior	superior		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350	5	25	2.5	mg/kg	bid	5		fidaxomicin	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	9	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350	5	25	2.5	mg/kg	bid	5		fidaxomicin	vehicle control	superior	superior		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350	50	250	25	mg/kg	bid	5		smt19969	vehicle control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	10	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350	50	250	25	mg/kg	bid	5		smt19969	vehicle control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	acute	10	0	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350								vehiclecontrol	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25652749	25652749	25652749.txt	TRUE	2015	sustained	10	0	Clostridium difficile infection	positive	spf	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	~100-350								vehiclecontrol	SMT19969 25 mg/kg BID	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	11	1	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	0.5x10^7								control	vancomycin	equivalent	equivalent		Y	TRUE	0.09090909090909091
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	sustained	11	0	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	0.5x10^7								control	vancomycin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	0.5x10^7	100	300	50	mg/kg	bid	3		vancomycin	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	sustained	6	1	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	0.5x10^7	100	300	50	mg/kg	bid	3		vancomycin	control	superior	superior		Y	TRUE	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	0.5x10^7	100	300	50	mg/kg	bid	3		more-dcbg(362e)	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	sustained	6	1	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	0.5x10^7	100	300	50	mg/kg	bid	3		more-dcbg(362e)	control	superior	superior		Y	TRUE	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	sustained	5	3	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	0.5x10^7	100	700	50	mg/kg	bid	7		more-dcbg(362e)	vancomycin	equivalent	equivalent		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	5	5	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	0.5x10^7	100	700	50	mg/kg	bid	7		more-dcbg(362e)	vancomycin	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	sustained	5	5	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	0.5x10^7	100	1400	50	mg/kg	bid	14		more-dcbg(362e)	vancomycin	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	5	5	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	0.5x10^7	100	1400	50	mg/kg	bid	14		more-dcbg(362e)	vancomycin	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	30736358	30736358.txt	TRUE	2019	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	89.5114 g, mean 100.4 g	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	10^2	30	93.75	10	ml/kg	tid	3.125		anti-cd-wpiinducesatcdaneutralizationcapacityof100	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	30736358	30736358.txt	TRUE	2019	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	89.5114 g, mean 100.4 g	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	10^2	30	93.75	10	ml/kg	tid	3.125		anti-cd-wpiinducesatcdaneutralizationcapacityof1000	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	30736358	30736358.txt	TRUE	2019	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	89.5114 g, mean 100.4 g	hamster		clindamycin+challenge		cumulativemortality	t	t	12	630	100		spores	10^2	30	93.75	10	ml/kg	tid	3.125		anti-cd-wpiinducesatcdaneutralizationcapacityof10000	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	30736358	30736358.txt	TRUE	2019	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	89.5114 g, mean 100.4 g	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	10^2	20	60	20	mg/kg	qd	3		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	30736358	30736358.txt	TRUE	2019	sustained	10	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	89.5114 g, mean 100.4 g	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	10^2	30	93.75	10	ml/kg	tid	3.125		anti-cd-wpiinducesatcdaneutralizationcapacityof100	Vancomycin	eqivalent	superior		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/30736358	30736358	30736358.txt	TRUE	2019	sustained	10	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	89.5114 g, mean 100.4 g	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	10^2	30	93.75	10	ml/kg	tid	3.125		anti-cd-wpiinducesatcdaneutralizationcapacityof1000	Vancomycin	eqivalent	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/30736358	30736358	30736358.txt	TRUE	2019	sustained	10	10	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	89.5114 g, mean 100.4 g	hamster		clindamycin+challenge		cumulativemortality	t	t	12	630	100		spores	10^2	30	93.75	10	ml/kg	tid	3.125		anti-cd-wpiinducesatcdaneutralizationcapacityof10000	Vancomycin	eqivalent	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	30736358	30736358.txt	TRUE	2019	sustained	10	1	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	89.5114 g, mean 100.4 g	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	10^2	20	60	20	mg/kg	qd	3		vancomycin	"anti-C. difficile 
 whey protein isolates (anti-CD-WPI)"	equivalent	inferior		Y	TRUE	0.1
https://pubmed.ncbi.nlm.nih.gov/7309245	7309245	7309245.txt	TRUE	1981	acute	30	24	Clostridium difficile	positive	n/a	goldensyrian	m		N/A	85	70-100g	hamster		vancomyin+challenge	clindamycin + challenge	survivors	f	p		49a	100000	cfu		10^5								cecalhomogenates	Negative Control	superior	NA		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/7309245	7309245	7309245.txt	TRUE	1981	acute	20	1	Clostridium difficile	positive	n/a	goldensyrian	m		N/A	85	70-100g	hamster		vancomyin+challenge	clindamycin + challenge	survivors	f	p		49a	100000	cfu		10^5								negativecontrol	cecal homogenates	superior	NA		Y	TRUE	0.05
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5	150	900	150	mg/kg	qd	6		metronidazole	vancomycin	inferior	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5	150	900	150	mg/kg	qd	6		nitazoxanide	metronidazole	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	acute	10	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5	30	180	30	mg/kg	qd	6		nitazoxanide	vancomycin	superior	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5	50	300	50	mg/kg	qd	6		vancomycin	metronidazole	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5	75	450	75	mg/kg	qd	6		nitazoxanide	metronidazole	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	acute	10	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5								salinecontrol	vancomycin	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	sustained	10	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5	150	900	150	mg/kg	qd	6		metronidazole	vancomycin	inferior	inferior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	sustained	10	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5	150	900	150	mg/kg	qd	6		nitazoxanide	metronidazole	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	sustained	10	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5	30	180	30	mg/kg	qd	6		nitazoxanide	vancomycin	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	sustained	10	3	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5	50	300	50	mg/kg	qd	6		vancomycin	metronidazole	superior	superior		Y	TRUE	0.3
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	sustained	10	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5	75	450	75	mg/kg	qd	6		nitazoxanide	metronidazole	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/10952564	10952564	10952564.txt	TRUE	2000	sustained	10	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t		ttu614	100000			10^5								salinecontrol	vancomycin	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/15388461	15388461	15388461.txt	TRUE	2004	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	113	100-125g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	20	100	20	mg/kg	qd	5		rifalazil	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/15388461	15388461	15388461.txt	TRUE	2004	acute	14	14	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	113	100-125g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	50	250	50	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/15388461	15388461	15388461.txt	TRUE	2004	acute	10	0	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	113	100-125g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5								vehiclecontrol	Negative Control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/15388461	15388461	15388461.txt	TRUE	2004	sustained	10	10	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	113	100-125g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	20	100	20	mg/kg	qd	5		rifalazil	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/15388461	15388461	15388461.txt	TRUE	2004	sustained	14	5	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	113	100-125g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	50	250	50	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	0.35714285714285715
https://pubmed.ncbi.nlm.nih.gov/15388461	15388461	15388461.txt	TRUE	2004	sustained	10	0	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	113	100-125g	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5								vehiclecontrol	Negative Control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	acute	10	8	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	p	87	vpi10463	100000	cfu		10^5	100	500	100	mg/kg	qd	5		rifaximin	Negative Control	inferior	NA		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	acute	20	18	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	100	500	100	mg/kg	qd	5		rifaximin	Negative Control	inferior	NA		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	acute	10	6	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	p	87	vpi10463	100000	cfu		10^5	25	125	25	mg/kg	qd	5		rifaximin	Negative Control	inferior	NA		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	acute	20	9	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	25	125	25	mg/kg	qd	5		rifaximin	Negative Control	inferior	NA		Y	TRUE	0.45
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	acute	10	7	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	p	87	vpi10463	100000	cfu		10^5	50	250	50	mg/kg	qd	5		rifaximin	Negative Control	inferior	NA		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	acute	20	13	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	50	250	50	mg/kg	qd	5		rifaximin	Negative Control	inferior	NA		Y	TRUE	0.65
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	acute	10	7	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	p	87	vpi10463	100000	cfu		10^5	50	250	50	mg/kg	qd	5		vancomycin	rifaximin	inferior	NA		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	acute	20	18	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	50	250	50	mg/kg	qd	5		vancomycin	rifaximin	inferior	NA		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	acute	10	0	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	p	87	vpi10463	100000	cfu		10^5								vehiclecontrol	Negative Control	inferior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	acute	20	0	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5								vehiclecontrol	Negative Control	inferior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	sustained	8	8	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	100	500	100	mg/kg	qd	5		rifaximin	Negative Control	inferior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	sustained	1	1	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	25	125	25	mg/kg	qd	5		rifaximin	Negative Control	inferior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	sustained	3	3	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	50	250	50	mg/kg	qd	5		rifaximin	Negative Control	inferior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	sustained	8	2	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5	50	250	50	mg/kg	qd	5		vancomycin	rifaximin	inferior	NA		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/18195066	18195066	18195066.txt	TRUE	2008	sustained	10	0	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A		N/A	hamster		clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	100000	cfu		10^5								vehiclecontrol	Negative Control	inferior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	0.2	1	0.2	mg/kg	qd	5		tiacumicinsb	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	0.2	1	0.2	mg/kg	qd	5		tiacumicinsc	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	0.2	1	0.2	mg/kg	qd	5		vancomycin	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	5	3	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t		2926	1000000			10^6	1	5	1	mg/kg	qd	5		tiacumicinsb	vancomycin	superior	superior		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	1	5	1	mg/kg	qd	5		tiacumicinsb	vancomycin	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	1	5	1	mg/kg	qd	5		tiacumicinsc	vancomycin	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	5	3	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t		2926	1000000			10^6	1	5	1	mg/kg	qd	5		vancomycin	Tiacumicins B	inferior	inferior		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	1	5	1	mg/kg	qd	5		vancomycin	Tiacumicins B	inferior	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	5	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t		2926	1000000			10^6	5	25	5	mg/kg	qd	5		tiacumicinsb	vancomycin	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	5	25	5	mg/kg	qd	5		tiacumicinsb	Tiacumicins C	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	5	25	5	mg/kg	qd	5		tiacumicinsc	Tiacumicins B	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	5	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t		2926	1000000			10^6	5	25	5	mg/kg	qd	5		vancomycin	Tiacumicins B	inferior	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	5	25	5	mg/kg	qd	5		vancomycin	Tiacumicins C	inferior	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	5	3	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t		2926	1000000			10^6								control	control	inferior	inferior		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	acute	8	6	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6								control	control	superior	superior		Y	TRUE	0.75
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	0.2	1	0.2	mg/kg	qd	5		tiacumicinsb	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	0.2	1	0.2	mg/kg	qd	5		tiacumicinsc	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	8	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	0.2	1	0.2	mg/kg	qd	5		vancomycin	control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	5	3	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t		2926	1000000			10^6	1	5	1	mg/kg	qd	5		tiacumicinsb	vancomycin	superior	superior		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	1	5	1	mg/kg	qd	5		tiacumicinsb	vancomycin	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	1	5	1	mg/kg	qd	5		tiacumicinsc	vancomycin	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	5	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t		2926	1000000			10^6	1	5	1	mg/kg	qd	5		vancomycin	Tiacumicins B	inferior	inferior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	8	1	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	1	5	1	mg/kg	qd	5		vancomycin	Tiacumicins B	inferior	inferior		Y	TRUE	0.125
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	5	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t		2926	1000000			10^6	5	25	5	mg/kg	qd	5		tiacumicinsb	vancomycin	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	5	25	5	mg/kg	qd	5		tiacumicinsb	Tiacumicins C	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	8	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	5	25	5	mg/kg	qd	5		tiacumicinsc	Tiacumicins B	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	5	5	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t		2926	1000000			10^6	5	25	5	mg/kg	qd	5		vancomycin	Tiacumicins B	inferior	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	8	3	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6	5	25	5	mg/kg	qd	5		vancomycin	Tiacumicins C	inferior	inferior		Y	TRUE	0.375
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	5	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t		2926	1000000			10^6								control	control	inferior	inferior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1929250	1929250.txt	TRUE	1991	sustained	8	2	C. difficile disease	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	oral	cumulativemortality	t	t	1	atcc9689	1000000			10^6								control	control	superior	superior		Y	TRUE	0.25
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	acute	10	10	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	p		huc2-4	1000000	cfu		10^6	1000	7000	1000	mg/kg	qd	7		gt160-246	Saline (control)	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	acute	10	7	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	t		huc2-4	1000000	cfu		10^6	1000	7000	1000	mg/kg	qd	7		gt160-246	Saline (control)	equivalent	equivalent		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	acute	10	7	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	t		huc2-4	1000000	cfu		10^6	1500	10500	1500	mg/kg	qd	7		gt160-246	Saline (control)	equivalent	equivalent		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	acute	10	10	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	t		huc2-4	1000000	cfu		10^6	210	1050	210	mg/kg	qd	5		metronidazole	Saline (control)	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	acute	10	8	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	p		huc2-4	1000000	cfu		10^6	500	3500	500	mg/kg	qd	7		gt160-246	Saline (control)	equivalent	equivalent		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	acute	10	9	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	t		huc2-4	1000000	cfu		10^6	500	3500	500	mg/kg	qd	7		gt160-246	Saline (control)	equivalent	equivalent		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	acute	10	0	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	p		huc2-4	1000000	cfu		10^6								salinecontrol	Saline (control)	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	sustained	10	9	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	p		huc2-4	1000000	cfu		10^6	1000	7000	1000	mg/kg	qd	7		gt160-246	Saline (control)	equivalent	equivalent		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	sustained	10	7	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	t		huc2-4	1000000	cfu		10^6	1000	7000	1000	mg/kg	qd	7		gt160-246	Saline (control)	equivalent	equivalent		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	sustained	10	7	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	t		huc2-4	1000000	cfu		10^6	1500	10500	1500	mg/kg	qd	7		gt160-246	Saline (control)	equivalent	equivalent		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	sustained	10	2	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	t		huc2-4	1000000	cfu		10^6	210	1050	210	mg/kg	qd	5		metronidazole	Saline (control)	equivalent	equivalent		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	sustained	10	7	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	p		huc2-4	1000000	cfu		10^6	500	3500	500	mg/kg	qd	7		gt160-246	Saline (control)	equivalent	equivalent		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	sustained	10	9	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	t		huc2-4	1000000	cfu		10^6	500	3500	500	mg/kg	qd	7		gt160-246	Saline (control)	equivalent	equivalent		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/11451694	11451694	11451694.txt	TRUE	2001	sustained	10	0	C. difficile disease	positive	n/a	n/a	n/a		N/A		N/A	hamster		challenge+clindamycin		cumulativemortality	t	p		huc2-4	1000000	cfu		10^6								salinecontrol	Saline (control)	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	0	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	10^7								control	vancomycin	equivalent	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	10^7	100	300	50	mg/kg	bid	3		vancomycin	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	3	1	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	10^7	12.5	37.5	6.25	mg/kg	bid	3		359e	vancomycin	equivalent	equivalent		Y	TRUE	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	5	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	10^7	25	75	12.5	mg/kg	bid	3		359e	control	superior	superior		Y	TRUE	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	10^7	50	150	25	mg/kg	bid	3		359e	vancomycin	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	10^7	100	300	50	mg/kg	bid	3		359e	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	10^7	12.5	37.5	6.25	mg/kg	bid	3		more-dcbg(362e)	vancomycin	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	10^7	25	75	12.5	mg/kg	bid	3		more-dcbg(362e)	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	10^7	50	150	25	mg/kg	bid	3		more-dcbg(362e)	vancomycin	equivalent	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	22203600	22203600.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	f		N/A	85	80-90g	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge		cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	10^7	100	300	50	mg/kg	bid	3		more-dcbg(362e)	control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	acute	6	2	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3x10^4	0.03	0.15	0.03	mg/kg	qd	5		fidaxomicin	Negative Control	superior	NA		Y	TRUE	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	acute	6	3	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3x10^4	0.3	1.5	0.3	mg/kg	qd	5		fidaxomicin	Negative Control	superior	NA		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	acute	6	6	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3x10^4	3	15	3	mg/kg	qd	5		fidaxomicin	Negative Control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	acute	6	5	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3x10^4	100	500	50	mg/kg	bid	5		vancomycin	Negative Control	superior	NA		Y	TRUE	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	acute	6	0	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3x10^4								negativecontrol	fidaxomicin 3 mg/kg	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	sustained	6	0	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3x10^4	0.03	0.15	0.03	mg/kg	qd	5		fidaxomicin	vancomycin 100 mg/kg	eqivalent	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	sustained	6	1	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3x10^4	0.3	1.5	0.3	mg/kg	qd	5		fidaxomicin	Negative Control	superior	NA		Y	TRUE	0.16666666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	sustained	6	0	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3x10^4								negativecontrol	vancomycin 100 mg/kg	eqivalent	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	acute	5	5	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	4x10^4	2	10	1	mg/kg	bid	5		fidaxomicin	Negative Control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	acute	5	1	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	4x10^4	1	1	1	mg/kg	qd	1		fidaxomicin	Negative Control	superior	NA		Y	TRUE	0.2
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	acute	5	0	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	4x10^4								negativecontrol	fidaxomicin 3 mg/kg	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	sustained	5	2	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	4x10^4	2	10	1	mg/kg	bid	5		fidaxomicin	Negative Control	superior	NA		Y	TRUE	0.4
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	sustained	5	0	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	4x10^4	1	1	1	mg/kg	qd	1		fidaxomicin	Negative Control	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	sustained	6	3	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	4x10^4	3	15	3	mg/kg	qd	5		fidaxomicin	Negative Control	superior	NA		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	sustained	6	0	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	4x10^4	100	500	50	mg/kg	bid	5		vancomycin	Negative Control	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/29439962	29439962	29439962.txt	TRUE	2018	sustained	5	0	Clostridium difficile infection	positive	n/a	goldensyrian	m		N/A		N/A	hamster		clindamycin+challenge	clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	4x10^4								negativecontrol	fidaxomicin 3 mg/kg	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/22869573	22869573	22869573.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	50000000	cfu		5x10^7	300	1500	150	mg/kg	bid	5		metronidazole	Negative Control	superior	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22869573	22869573	22869573.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	50000000	cfu		5x10^7	100	500	50	mg/kg	bid	5		rbx14255	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22869573	22869573	22869573.txt	TRUE	2012	acute	6	6	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	50000000	cfu		5x10^7	100	500	50	mg/kg	bid	5		vancomycin	Negative Control	superior	equivalent		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/22869573	22869573	22869573.txt	TRUE	2012	sustained	6	0	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	50000000	cfu		5x10^7	300	1500	150	mg/kg	bid	5		metronidazole	Negative Control	superior	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/22869573	22869573	22869573.txt	TRUE	2012	sustained	6	3	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	50000000	cfu		5x10^7	100	500	50	mg/kg	bid	5		rbx14255	Negative Control	superior	superior		Y	TRUE	0.5
https://pubmed.ncbi.nlm.nih.gov/22869573	22869573	22869573.txt	TRUE	2012	sustained	6	0	C. difficile disease	positive	n/a	goldensyrian	n/a		N/A	90	80-100g	hamster		clindamycin+challenge		cumulativemortality	f	t	12	atcc43596	50000000	cfu		5x10^7	100	500	50	mg/kg	bid	5		vancomycin	Negative Control	superior	equivalent		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/33782498	33782498	33782498.txt	TRUE	2021	acute	20	20	Clostridioides difficile infections	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		7.5x10^6	20	100	20	mg/kg	qd	5		vancomycin	Negative Control	superior	NA		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/33782498	33782498	33782498.txt	TRUE	2021	acute	20	1	Clostridioides difficile infections	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		7.5x10^6								negativecontrol	vancomycin	superior	NA		Y	TRUE	0.05
https://pubmed.ncbi.nlm.nih.gov/33782498	33782498	33782498.txt	TRUE	2021	sustained	20	14	Clostridioides difficile infections	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		7.5x10^6	20	100	20	mg/kg	qd	5		vancomycin	Negative Control	superior	NA		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/33782498	33782498	33782498.txt	TRUE	2021	sustained	20	0	Clostridioides difficile infections	positive	n/a	goldensyrian	m		N/A	90	80-100g	hamster		clindamycin+challenge	clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		7.5x10^6								negativecontrol	vancomycin	superior	NA		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	acute	10	10	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin	challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		5.11 to 6.22 log10	10	50	10	mg/kg	qd	5		smt19969	vancomycin	equivalent	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	acute	20	20	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin	challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		5.11 to 6.22 log10	20	100	20	mg/kg	qd	5		smt19969	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	acute	20	20	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin	challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		5.11 to 6.22 log10	20	100	20	mg/kg	qd	5		vancomycin	SMT19969 [2,2'-bis(4-pyridyl)3H,3'-H 5,5-bibenzimidazole]	equivalent	inferior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	acute	20	20	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin		cumulativemortality	t	t	27	va5	894206	cfu		5.11 to 6.22 log10	50	250	50	mg/kg	qd	5		smt19969	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	sustained	10	0	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin	challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		5.11 to 6.22 log10	10	50	10	mg/kg	qd	5		smt19969	Negative Control	superior	superior		Y	TRUE	0.0
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	sustained	20	11	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin	challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		5.11 to 6.22 log10	20	100	20	mg/kg	qd	5		smt19969	SMT19969 [2,2'-bis(4-pyridyl)3H,3'-H 5,5-bibenzimidazole]	equivalent	inferior		Y	TRUE	0.55
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	sustained	20	11	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin	challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		5.11 to 6.22 log10	40	200	20	mg/kg	bid	5		vancomycin	SMT19969 [2,2'-bis(4-pyridyl)3H,3'-H 5,5-bibenzimidazole]	equivalent	inferior		Y	TRUE	0.55
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	sustained	20	14	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin	challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		5.11 to 6.22 log10	50	250	50	mg/kg	qd	5		smt19969	vancomycin	equivalent	superior		Y	TRUE	0.7
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	acute	10	9	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin		cumulativemortality	t	t	428	va11	752846	cfu		5.44 to 6.09 log10	10	50	10	mg/kg	qd	5		smt19969	Negative Control	superior	superior		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	acute	20	19	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin		cumulativemortality	t	t	428	va11	752846	cfu		5.44 to 6.09 log10	20	100	20	mg/kg	qd	5		smt19969	Negative Control	superior	superior		Y	TRUE	0.95
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	acute	20	20	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin		cumulativemortality	t	t	428	va11	752846	cfu		5.44 to 6.09 log10	20	100	20	mg/kg	qd	5		vancomycin	Negative Control	superior	superior		Y	TRUE	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	acute	20	19	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin		cumulativemortality	t	t	428	va11	752846	cfu		5.44 to 6.09 log10	50	250	50	mg/kg	qd	5		smt19969	Negative Control	superior	superior		Y	TRUE	0.95
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	sustained	10	8	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin		cumulativemortality	t	t	428	va11	752846	cfu		5.44 to 6.09 log10	10	50	10	mg/kg	qd	5		smt19969	vancomycin	inferior	superior		Y	TRUE	0.8
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	sustained	20	18	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin		cumulativemortality	t	t	428	va11	752846	cfu		5.44 to 6.09 log10	20	100	20	mg/kg	qd	5		smt19969	vancomycin	inferior	superior		Y	TRUE	0.9
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	sustained	20	12	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin		cumulativemortality	t	t	428	va11	752846	cfu		5.44 to 6.09 log10	20	100	20	mg/kg	qd	5		vancomycin	SMT19969 [2,2'-bis(4-pyridyl)3H,3'-H 5,5-bibenzimidazole]	superior	inferior		Y	TRUE	0.6
https://pubmed.ncbi.nlm.nih.gov/25022586	25022586	25022586.txt	TRUE	2014	sustained	20	19	C. difficile disease	positive	n/a	goldensyrian	m		N/A	100	80-120g	hamster		challenge+clindamycin		cumulativemortality	t	t	428	va11	752846	cfu		5.44 to 6.09 log10	50	250	50	mg/kg	qd	5		smt19969	vancomycin	inferior	superior		Y	TRUE	0.95
